PLoS ONE
(Jan 2019)
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
Nao Tokai,
Shuzo Yoshida,
Takuya Kotani,
Ayaka Yoshikawa,
Yuko Kimura,
Youhei Fujiki,
Yoko Matsumura,
Tohru Takeuchi,
Shigeki Makino,
Shigeki Arawaka
Affiliations
Nao Tokai
Shuzo Yoshida
Takuya Kotani
Ayaka Yoshikawa
Yuko Kimura
Youhei Fujiki
Yoko Matsumura
Tohru Takeuchi
Shigeki Makino
Shigeki Arawaka
DOI
https://doi.org/10.1371/journal.pone.0211750
Journal volume & issue
Vol. 14,
no. 1
p.
e0211750
Abstract
Read online
[This corrects the article DOI: 10.1371/journal.pone.0202601.].
WeChat QR code
Close